ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
避孕概念
1,476.74
+44.85
3.13%
涨家数:
5
跌家数:
1
平家数:
- -
市盈率:
- -
高:
1,490.06
开:
1,431.18
低:
1,413.78
收:
1,431.88
成交量:
3,572.79万
成交额:
3.02亿
市值:
233.44亿
流通市值:
231.85亿
数据加载中...
总览
新闻
Femasys Inc完成800万美元融资,加速推进生育和避孕产品组合商业化进程
美股速递
·
昨天
BUZZ-肺病药物达到主要研究目标后,United Therapeutics 公司业绩大涨
路透中文
·
昨天
美国FDA批准梯瓦制药的肥胖症仿制药
格隆汇
·
08/28
美股异动 | Femasys(FEMY.US)股价重挫37% 创年内新低
智通财经
·
08/26
生物技术公司Femasys重挫35.7%,此前宣布将公开发行募集800万美元资金
环球市场播报
·
08/26
美股周二早盘生物技术公司Femasys(FEMY)股价重挫35.7%此前该公司宣布通过公开发行募集800万美元资金所筹资
智通财经
·
08/26
Femasys宣布800万美元承销公开发行定价
投资观察
·
08/26
BUZZ-ScPharmaceuticals 在 MannKind 收购交易后上涨
路透中文
·
08/25
曼恩凯德生物医疗收购scPharmaceuticals 加速营收增长并成为心脏代谢和肺部疾病领域以患者为中心的领导者
美股速递
·
08/25
爱尔康盘中异动 股价大跌7.78%报83.11美元
市场透视
·
08/20
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4584/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"避孕概念","latestPrice":1476.7368,"timestamp":1756839566649,"preClose":1431.8818,"halted":0,"volume":35728068,"delay":0,"changeRate":0.031326,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":44.85498,"latestTime":"09-02 14:59:27 EDT","open":1431.18,"high":1490.0564,"low":1413.7831,"amount":302166434.618576,"amplitude":0.053268,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1756843200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.251046,"peRate":-82.562198,"turnoverRate":0.023637,"increases":5,"decrements":1,"flats":0,"marketCap":23343756816,"floatMarketCap":23185449296},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":1490.0564,"amplitude":0.053268,"preClose":1431.8818,"low":1413.7831,"pbRate":"3.251046","latestPrice":1476.7368,"volume":35727878,"delay":0,"open":1431.18,"prevYearClose":1682.2216,"prevWeekClose":1431.8818,"prevMonthClose":1431.8818,"prevQuarterClose":1256.7808,"fiveDayClose":1399.5216,"twentyDayClose":1195.9888,"sixtyDayClose":1303.5731,"secType":"PLATE","market":"US","turnoverRate":0.023636,"peRate":-82.562198,"marketCap":23343756816,"floatMarketCap":23185449296,"timestamp":1756839564933,"nameCN":"避孕概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":5,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102913498","title":"Femasys Inc完成800万美元融资,加速推进生育和避孕产品组合商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1102913498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102913498?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 21:00","pubTimestamp":1756818029,"startTime":"0","endTime":"0","summary":"Femasys Inc完成800万美元融资,加速推进生育和避孕产品组合商业化进程","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4539","FEMY","BK4082"],"gpt_icon":0},{"id":"2564902807","title":"BUZZ-肺病药物达到主要研究目标后,United Therapeutics 公司业绩大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2564902807","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564902807?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 20:43","pubTimestamp":1756817001,"startTime":"0","endTime":"0","summary":"(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nL4S3UP0ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","LU1699723380.USD","BK4584","LU1571399168.USD","MNKD","BK4139","BK4532"],"gpt_icon":0},{"id":"2562403716","title":"美国FDA批准梯瓦制药的肥胖症仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2562403716","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562403716?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 20:58","pubTimestamp":1756385890,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","LU0154236417.USD","BK4007","BK4559","BK4557","BK4596","NVO","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","BK4599","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","TEVA","BK4588","BK4584"],"gpt_icon":0},{"id":"2562758131","title":"美股异动 | Femasys(FEMY.US)股价重挫37% 创年内新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2562758131","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562758131?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 23:21","pubTimestamp":1756221690,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FEMY","BK4584","BK4082","BK4539"],"gpt_icon":0},{"id":"2562213730","title":"生物技术公司Femasys重挫35.7%,此前宣布将公开发行募集800万美元资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2562213730","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562213730?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 23:09","pubTimestamp":1756220940,"startTime":"0","endTime":"0","summary":"美股周二早盘,生物技术公司Femasys(FEMY)股价重挫35.7%,此前该公司宣布通过公开发行募集800万美元资金,所筹资金将用于支持该公司的商业扩张和产品开发计划。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-26/doc-infnismx6485746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4539","FEMY","BK4584","BK4082"],"gpt_icon":0},{"id":"2562302577","title":"美股周二早盘生物技术公司Femasys(FEMY)股价重挫35.7%此前该公司宣布通过公开发行募集800万美元资金所筹资","url":"https://stock-news.laohu8.com/highlight/detail?id=2562302577","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562302577?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 23:08","pubTimestamp":1756220898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4584","BK4082","FEMY","BK4539"],"gpt_icon":0},{"id":"1118350903","title":"Femasys宣布800万美元承销公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1118350903","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118350903?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 11:48","pubTimestamp":1756180099,"startTime":"0","endTime":"0","summary":"公司今日宣布了一项承销公开发行的定价,发行1,043.46万股普通股,或以预付认股权证替代购买最多1,175万股普通股,同时配发普通认股权证可购买总计最多2,218.46万股普通股。所有配套认股权证自发行日起立即可行权,有效期为发行日起五年。在扣除承销折扣和佣金以及Femasys需支付的其他公开发行费用之前,此次发行预计为Femasys带来约800万美元的毛收入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4528","BK4082","BK4232","BK4584","BK4233","FEMY","BK4022","BK4539","UK","BK4205"],"gpt_icon":0},{"id":"2562843241","title":"BUZZ-ScPharmaceuticals 在 MannKind 收购交易后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2562843241","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562843241?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 20:17","pubTimestamp":1756124261,"startTime":"0","endTime":"0","summary":"BUZZ-ScPharmaceuticals 在 MannKind 收购交易后上涨8月25日 - ** 制药公司scPharmaceuticals SCPH.O的股价盘前上涨13.2%至5.48美元 ** 生物技术公司MannKind公司MNKD.O将收购scPharmaceuticals,交易价值高达3.6亿美元。** 交易预计在第四季度完成** 截至上一交易日收盘,MNKD 下跌 36.1%,而 SCPH 则累计上涨 37 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4S3UH0RP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SCPH","MNKD","BK4584"],"gpt_icon":0},{"id":"1135181145","title":"曼恩凯德生物医疗收购scPharmaceuticals 加速营收增长并成为心脏代谢和肺部疾病领域以患者为中心的领导者","url":"https://stock-news.laohu8.com/highlight/detail?id=1135181145","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135181145?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 19:31","pubTimestamp":1756121507,"startTime":"0","endTime":"0","summary":"曼恩凯德生物医疗收购scPharmaceuticals,加速营收增长并成为心脏代谢和肺部疾病领域以患者为中心的领导者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SCPH","BK4584","BK4007","MNKD"],"gpt_icon":0},{"id":"2560710227","title":"爱尔康盘中异动 股价大跌7.78%报83.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560710227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560710227?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 21:31","pubTimestamp":1755696719,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日21时31分,爱尔康股票出现波动,股价急速下挫7.78%。截至发稿,该股报83.11美元/股,成交量36.7482万股,换手率0.07%,振幅1.48%。爱尔康股票所在的医疗设备行业中,整体跌幅为0.16%。爱尔康经营两个部门:视力护理部门和外科部门。爱尔康拥有世界上最大的眼科手术设备安装基地之一。爱尔康将其净销售额预期区间从5月份的104亿-105亿美元下调至103亿-104亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820213159a6f151b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820213159a6f151b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4539","FEMY","BK4584"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}